Unfit to intensive chemotherapy
Showing 1 - 25 of >10,000
Acute Myeloid Leukemia Trial in Firenze (Venetoclax+Decitabine)
Recruiting
- Acute Myeloid Leukemia
-
Firenze, ItalyAz. Ospedaliero - Universitaria Careggi
Jan 3, 2022
MDS, Acute Myeloid Leukemia Trial in France (BST-236)
Recruiting
- Myelodysplastic Syndromes
- Acute Myeloid Leukemia
-
Amiens, France
- +16 more
Jan 2, 2023
Leukemia, Myeloid, Acute Trial (The combination of HHT, venetoclax, AZA, G-CSF)
Not yet recruiting
- Leukemia, Myeloid, Acute
- The combination of HHT, venetoclax, AZA, G-CSF
- (no location specified)
Mar 28, 2021
Acute Myeloid Leukemia, MDS Trial (Cladribine, Cytarabine, Decitabine)
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Cladribine
- +4 more
- (no location specified)
Mar 1, 2023
ACUTE MYELOID LEUKEMIA Trial in New Haven (Glasdegib, Decitabine)
Terminated
- ACUTE MYELOID LEUKEMIA
-
New Haven, ConnecticutYale Cancer Center/Smilow
Sep 18, 2021
Neuroendocrine Tumors, Frailty, Chemo Effect Trial in Milan (Temozolomide capsule)
Recruiting
- Neuroendocrine Tumors
- +2 more
- Temozolomide capsule
-
Milan, ItalyEuropean Institute of Oncology, IEO, IRCCS
Sep 21, 2022
Acute Myeloid Leukemia Trial in United States (Quizartinib, Milademetan)
Terminated
- Acute Myeloid Leukemia
-
Los Angeles, California
- +7 more
Mar 14, 2022
Acute Myeloid Leukemia Trial in France (GRASPA)
Completed
- Acute Myeloid Leukemia
-
Nice, Alpes Maritimes, France
- +20 more
Feb 18, 2022
NSCLC, Stage III Trial in Germany (Durvalumab Injection [Imfinzi], Thoracic Radiotherapy (TRT) conventionally, Thoracic
Recruiting
- NSCLC, Stage III
- Durvalumab Injection [Imfinzi]
- +2 more
-
Aachen, Germany
- +13 more
Nov 29, 2022
Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in
Not yet recruiting
- Acute Myeloid Leukemia
- (no location specified)
Sep 22, 2023
Acute Myeloid Leukemia Trial in Germany (Venetoclax plus Azacitidine, standard of care chemo plus gemtuzumab ozogamicin)
Not yet recruiting
- Acute Myeloid Leukemia
- Venetoclax plus Azacitidine
- standard of care chemotherapy plus gemtuzumab ozogamicin
-
Essen, NRW, Germany
- +17 more
Jun 6, 2023
Acute Myeloid Leukemia Trial in Worldwide (MBG453, Venetoclax, Azacitidine)
Active, not recruiting
- Acute Myeloid Leukemia
- MBG453
- +2 more
-
Birmingham, Alabama
- +27 more
Jan 20, 2023
Acute Myeloid Leukemia, MDS Trial (idarubicin, Cytarabine)
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- (no location specified)
Sep 18, 2023
Acute Myeloid Leukemia, Myelodysplastic Tumor Trial (Magrolimab, 7+3, CPX-351)
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Neoplasm
- Magrolimab
- +2 more
- (no location specified)
Apr 24, 2023
Acute Myeloid Leukemia, in Relapsed or Refractory, Acute Myeloid Leukemia, Elderly, Unfit, Acute Myeloid Leukemia With Positive
Unknown status
- Acute Myeloid Leukemia, in Relapsed or Refractory
- +2 more
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Sep 8, 2020
Acute Myeloid Leukemia (AML) Trial in Austria, Italy, Spain (Ivosidenib Oral Tablet, Azacitidine)
Not yet recruiting
- Acute Myeloid Leukemia (AML)
- Ivosidenib Oral Tablet
- Azacitidine
-
Vienna, Austria
- +3 more
Jun 8, 2023
Pancreatic Cancer Non-resectable Trial in Amsterdam, Utrecht (stereotactic ablative radiotherapy)
Recruiting
- Pancreatic Cancer Non-resectable
- stereotactic ablative radiotherapy
-
Amsterdam, Noord-Holland, Netherlands
- +1 more
Feb 22, 2022
Unfit AML Patients Treated With Combination Venetoclax Plus
Recruiting
- Acute Myeloid Leukemia
- Venetoclax plus HMA
-
Bergamo, Italy
- +22 more
Oct 10, 2022
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Secondary Acute Myeloid Leukemia
Recruiting
- Acute Myeloid Leukemia
- +3 more
- Azacitidine
- +5 more
-
Greenwich, Connecticut
- +27 more
Dec 30, 2022
Penile Cancer, Advanced Cancer, Metastatic Cancer Trial in Toronto (Avelumab, Best Supportive Care)
Recruiting
- Penile Cancer
- +2 more
- Avelumab
- Best Supportive Care
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Nov 26, 2021
Acute Monocytic Leukemia, Newly Diagnosed Trial in Suzhou (Chidamide, Azacitidine, Venetoclax)
Recruiting
- Acute Monocytic Leukemia
- Newly Diagnosed
- Chidamide
- +2 more
-
Suzhou, Jiangsu, ChinaThe First Affliated Hospital of Soochow University
Oct 3, 2022
Locally Advanced Lung Non-Small Cell Carcinoma Trial in Terni (Stereotactic Ablative Radiotherapy in Unresectable Locally
Completed
- Locally Advanced Lung Non-Small Cell Carcinoma
- Stereotactic Ablative Radiotherapy in Unresectable Locally Advanced Non-Small Cell Lung Cancer
-
Terni, TR, ItalyRadiotherapy Oncology Centre "S.Maria" Hospital
Mar 22, 2022